PL445753A1 - Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie - Google Patents
Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanieInfo
- Publication number
- PL445753A1 PL445753A1 PL445753A PL44575323A PL445753A1 PL 445753 A1 PL445753 A1 PL 445753A1 PL 445753 A PL445753 A PL 445753A PL 44575323 A PL44575323 A PL 44575323A PL 445753 A1 PL445753 A1 PL 445753A1
- Authority
- PL
- Poland
- Prior art keywords
- benzyloxycarbonylamino
- amidino
- naphthyl
- ester hydrochloride
- methylcarboxy
- Prior art date
Links
- -1 Benzyloxycarbonylamino-[(6-amidino)naphthyl]methanephosphonic acid Chemical compound 0.000 title abstract 4
- 241000607715 Serratia marcescens Species 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku jest chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metano-fosfonowego o wzorze 1 i jego zastosowanie jako środka przeciwbakteryjnego do eliminowania bakterii Serratia marcescens.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL445753A PL445753A1 (pl) | 2023-08-03 | 2023-08-03 | Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL445753A PL445753A1 (pl) | 2023-08-03 | 2023-08-03 | Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL445753A1 true PL445753A1 (pl) | 2025-02-10 |
Family
ID=94479885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL445753A PL445753A1 (pl) | 2023-08-03 | 2023-08-03 | Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL445753A1 (pl) |
-
2023
- 2023-08-03 PL PL445753A patent/PL445753A1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4491199A3 (en) | Gadolinium bearing pcta-based contrast agents | |
| DK0705254T3 (da) | Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer | |
| BR0316606A (pt) | Derivados de aminoindazóis e sua utilização como inibidores de quinases | |
| GEP20267862B (en) | Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof | |
| EA200400073A1 (ru) | Пирролопиримидины как ингибиторы протеинкиназы | |
| BR112018009297A8 (pt) | composição de limpeza e desinfecção | |
| BR0010555A (pt) | Inibidores de neuraminidases | |
| CR20230485A (es) | Derivados de fósforo como nuevos inhibidores de sos1 | |
| UY25780A1 (es) | Nuevos antibióticos macrólidos | |
| ZA202301937B (en) | Compounds | |
| CR10974A (es) | Inhibidores de carboxipeptidasa b plasmatica (divisional) | |
| CY1108498T1 (el) | Συνθεση εμβολιου η οποια περιεχει ως εκδοχο μια αλκυλφωσφατιδυλοχολινη | |
| MX2022015679A (es) | Inhibidor de tyk-2. | |
| EA200401183A1 (ru) | Применение ингибиторов il-18 в качестве диагностического маркера | |
| MX2025012370A (es) | Compuesto de amida, composicion farmaceutica que comprende el compuesto y uso de esta | |
| MX2024010712A (es) | Sal de cabozantinib con ácido l-(+)-tartárico y formas sólidas de esta | |
| MX2024015922A (es) | Degradadores de proteinas del factor 2 relacionado con el eritroide de factor nuclear 2 (nrf2) | |
| BRPI0406824A (pt) | Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm | |
| PL445753A1 (pl) | Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie | |
| ATE187461T1 (de) | Cyklopeptolide | |
| NO983511D0 (no) | Difenylstilbener som pro-legemidler for COX-2-inhibitorer | |
| PL445752A1 (pl) | Chlorowodorek estru p-merkaptometylo-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie | |
| MX2024003859A (es) | Inhibidores de lpxc y usos de estos. | |
| MX2022011593A (es) | Formas cristalinas de un compuesto farmaceutico. | |
| BR9909870A (pt) | Pirrolidinas como inibidores de neuraminidases |